Clincosm LogoSign in Get a demo

Ocular Hypertension

Showing NaN - NaN of 28
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glaucoma, Open-Angle, Ocular Hypertension Trial in Worldwide (Bimatoprost SR, Sham Bimatoprost SR, Selective Laser

Active, not recruiting
  • Glaucoma, Open-Angle
  • Ocular Hypertension
  • Bimatoprost SR
  • +3 more
  • Dothan, Alabama
  • +94 more
Nov 1, 2022

Open-Angle Glaucoma, Ocular Hypertension Trial in Worldwide (Bimatoprost (SR))

Recruiting
  • Open-Angle Glaucoma
  • Ocular Hypertension
  • Bimatoprost (SR)
  • Sun City, Arizona
  • +112 more
Aug 16, 2022

Glaucoma, Open-Angle, Ocular Hypertension Trial in United States (Test - Bimatoprost 0.01% Ophthalmic Solution, Reference -

Recruiting
  • Glaucoma, Open-Angle
  • Ocular Hypertension
  • Test - Bimatoprost 0.01% Ophthalmic Solution
  • Reference - LUMIGAN® (Bimatoprost 0.01% Ophthalmic Solution)
  • Newport Beach, California
  • +8 more
Aug 9, 2022

Open-Angle Glaucoma, Ocular Hypertension Trial in United States (Bimatoprost SR, LUMIGAN)

Completed
  • Open-Angle Glaucoma
  • Ocular Hypertension
  • Dothan, Alabama
  • +5 more
May 17, 2022

Open Angle Glaucoma, Ocular Hypertension Trial in United States (OTX-TIC low dose Travoprost Intracameral Implant, OTX-TIC high

Recruiting
  • Open Angle Glaucoma
  • Ocular Hypertension
  • OTX-TIC low dose Travoprost Intracameral Implant
  • +2 more
  • Delray Beach, Florida
  • +8 more
Apr 12, 2022

Open Angle Glaucoma, Ocular Hypertension Trial in United States (Travoprost, Placebo Vehicle)

Completed
Has Results
  • Open Angle Glaucoma
  • Ocular Hypertension
  • Artesia, California
  • +9 more
Sep 14, 2021

Ocular Hypertension, Open Angle Glaucoma Trial in United States (OTX-TIC)

Active, not recruiting
  • Ocular Hypertension
  • Open Angle Glaucoma
  • Petaluma, California
  • +4 more
Jun 9, 2021

Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (PF-04217329 - Lowest Dose, PF-04217329 - Low Dose,

Completed
Has Results
  • Primary Open-Angle Glaucoma
  • Ocular Hypertension
  • PF-04217329 - Lowest Dose
  • +8 more
  • Artesia, California
  • +22 more
Apr 6, 2021

Open Angle Glaucoma, Ocular Hypertension Trial in United States (Xalacom, Xalatan, Timolol)

Completed
  • Open Angle Glaucoma
  • Ocular Hypertension
  • Birmingham, Alabama
  • +63 more
Feb 17, 2021

Ocular Hypertension, Glaucoma Trial in United States (latanoprost 0.005%, fixed combination latanoprost-timolol, timolol 0.5%)

Completed
  • Ocular Hypertension
  • Glaucoma
  • latanoprost 0.005%
  • +2 more
  • Anaheim, California
  • +52 more
Feb 17, 2021

Ocular Hypertension, Primary Open Angle Glaucoma Trial in United States (Latanoprost ophthalmic solution, AKB-9778, Placebo)

Completed
  • Ocular Hypertension
  • Primary Open Angle Glaucoma
  • Latanoprost ophthalmic solution
  • +2 more
  • Inglewood, California
  • +20 more
Jan 13, 2021

Glaucoma, Open-Angle, Ocular Hypertension Trial in United States (Netarsudil Ophthalmic Solution 0.02%)

Completed
Has Results
  • Glaucoma, Open-Angle
  • Ocular Hypertension
  • Netarsudil Ophthalmic Solution 0.02%
  • Huntington Beach, California
  • +21 more
Sep 8, 2020

Primary Open Angle Glaucoma, Ocular Hypertension, Pigmentary Glaucoma Trial in United States (PF-03187207 and Latanoprost

Completed
Has Results
  • Primary Open Angle Glaucoma
  • +3 more
  • PF-03187207 and Latanoprost Vehicle
  • Latanoprost 0.005% and PF-03187207 Vehicle
  • Artesia, California
  • +18 more
Sep 10, 2020

Glaucoma, Open-Angle, Ocular Hypertension Trial in Worldwide (Bimatoprost SR, Active Comparator: Timolol 0.5%, Sham: Applicator

Completed
Has Results
  • Glaucoma, Open-Angle
  • Ocular Hypertension
  • Bimatoprost SR
  • +3 more
  • Phoenix, Arizona
  • +105 more
May 29, 2020

Glaucoma, Open-angle, Ocular Hypertension Trial in United States (0.01% RO7058584, 0.1% RO7058584, 1% RO7058584)

Completed
  • Glaucoma, Open-angle
  • Ocular Hypertension
  • 0.01% RO7058584
  • +4 more
  • Chandler, Arizona
  • +7 more
Mar 27, 2020

Open-Angle Glaucoma, Ocular Hypertension Trial in Worldwide (bimatoprost 20 µg generation 2, bimatoprost 15 µg generation 2,

Completed
Has Results
  • Open-Angle Glaucoma
  • Ocular Hypertension
  • bimatoprost 20 µg generation 2
  • +6 more
  • Artesia, California
  • +56 more
Mar 27, 2020

Ocular Hypertension, Primary Open Angle Glaucoma Trial in Austin, Dallas (AKB-9778 Ophthalmic Solution, Placebo Ophthalmic

Completed
  • Ocular Hypertension
  • Primary Open Angle Glaucoma
  • AKB-9778 Ophthalmic Solution
  • Placebo Ophthalmic Solution
  • Austin, Texas
  • +1 more
Feb 24, 2020

Open Angle Glaucoma, Ocular Hypertension Trial in United States (PG324 Ophthalmic Solution 0.01%, PG324 Ophthalmic Solution

Completed
Has Results
  • Open Angle Glaucoma
  • Ocular Hypertension
  • PG324 Ophthalmic Solution 0.01%
  • +3 more
  • Artesia, California
  • +22 more
May 14, 2019

Open-angle Glaucoma, Ocular Hypertension Trial in United States (DE-117 Low Dose ophthalmic solution, DE-117 Low/Middle Dose

Completed
  • Open-angle Glaucoma
  • Ocular Hypertension
  • DE-117 Low Dose ophthalmic solution
  • +5 more
  • Chandler, Arizona
  • +13 more
Apr 16, 2018

Ocular Hypertension, Open Angle Glaucoma Trial in United States (AR-13324 Ophthalmic Solution 0.01%, AR-13324 Ophthalmic

Completed
Has Results
  • Ocular Hypertension
  • Open Angle Glaucoma
  • AR-13324 Ophthalmic Solution 0.01%
  • +3 more
  • Newport Beach, California
  • +10 more
Mar 19, 2018

Ocular Hypertension, Open Angle Glaucoma Trial in United States (AR-13324 Ophthalmic Solution 0.01%, AR-13324 Ophthalmic

Completed
Has Results
  • Ocular Hypertension
  • Open Angle Glaucoma
  • AR-13324 Ophthalmic Solution 0.01%
  • +2 more
  • Artesia, California
  • +21 more
Mar 19, 2018

Ocular Hypertension, Open Angle-glaucoma Trial in United States (ONO-9054, Latanoprost)

Completed
  • Ocular Hypertension
  • Open Angle-glaucoma
  • Los Angeles, California
  • +11 more
Jan 26, 2016

Primary Open-angle Glaucoma, Ocular Hypertension Trial in United States (LX7101 (0.125%), LX7101 (0.25%), LX7101 Vehicle)

Completed
  • Primary Open-angle Glaucoma
  • Ocular Hypertension
  • LX7101 (0.125%)
  • +2 more
  • Morrow, Georgia
  • +4 more
Aug 31, 2015

Open Angle Glaucoma, Ocular Hypertension Trial in United States (PG286 Ophthalmic Solution 0.5%, AR-12286 Ophthalmic Solution

Completed
  • Open Angle Glaucoma
  • Ocular Hypertension
  • PG286 Ophthalmic Solution 0.5%
  • +2 more
  • Artesia, California
  • +20 more
Feb 17, 2014

Primary Open-angle Glaucoma, Ocular Hypertension Trial in United States (OPA-6566, Placebo, Latanoprost)

Completed
  • Primary Open-angle Glaucoma
  • Ocular Hypertension
  • Artesia, California
  • +8 more
Feb 7, 2014